/PRNewswire/ Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that nearly 2,000 people with amyotrophic lateral sclerosis (ALS) have received.
Mitsubishi Tanabe Pharma America Celebrates Nearly 2,000 ALS Patients Treated With RADICAVA ORS® (edaravone) businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.